• Navigation

    • Home
    • About
    • Research
    • Dendritic Cell
    • Pipeline
    • News
    • Contact
  • About
  • Science
    • Research
    • Dendritic Cell
  • Pipeline
  • News
    • News
    • Press Releases
    • Presentations
    • Publications
  • Contact

Publications

Science Translational Medicine: A Unique Subset of Cytotoxic Effector Memory T-cells Enhances CAR T-cell Function against Pancreatic Ductal Adenocarcinoma. Konduri V, Joseph S, Byrd TT, et al.

May 5, 2022

FASEB Journal: MHC class I and II peptide homology regulates the cellular immune response. FASEB. Halpert MM, Konduri V, Liang D, et al.

April 16, 2020

Cancer Gene Therapy: Dendritic cell vaccination plus low-dose Doxorubicin for the treatment of spontaneous canine hemangiosarcoma. Konduri V*, Halpert MM*, et al. Cancer Gene Therapy.

January 23, 2019

Frontiers in Immunology: AIMp1 Potentiates TH1 polarization and is critical for effective antitumor and antiviral immunity. Liang D, Tian L, You R, et al.

January 15, 2018

OncoImmunology: Chemo-immunotherapy mediates durable cure of orthotopic KrasG12D/p53-/- pancreatic ductal adenocarcinoma. Oncoimmunology. Konduri V, Li D, Halpert MM, et al.

July 22, 2016

Stem Cells Development: Dendritic cell- secreted cytotoxic T-lymphocyte-associated protein-4 regulates the T-cell response by downmodulating bystander surface. Halpert, MM, Konduri, V, Liang, D, et al.

May 15, 2016

Blood: Th-1 Polarization is Regulated by Dendritic Cell Comparison of MHC Class I and Class II Antigens. Decker WK, Xing D, Li S, et al. Blood.

April 30, 2009

Vaccine: Double Loading of Dendritic Cell MHC Class I and MHC Class II with an AML Antigen Repertoire Enhances Correlates of T-cell Immunity In Vitro via Amplification of T-cell Help. Decker WK, Xing D, Li S, et al.

January 29, 2006

Serving the Patient,
not the Cancer.

    • About
    • Research
    • Dendritic Cell
    • Pipeline
    • News
    • Contact
Expanded Access Program

©2025 Diakonos Oncology Corporation